This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

LexisNexis Unveils LexisNexis MedMal Navigator – Interactive Litigation Tool Significantly Streamlines Complex Medical Malpractice Case Preparation

LexisNexis® Legal & Professional, a leading provider of content and technology solutions, today introduced LexisNexis ® MedMal Navigator SM, a new interactive, all-in-one medical malpractice dashboard tool designed to help medical malpractice attorneys formulate the appropriate on-point strategy for their case more efficiently and cost-effectively. The MedMal Navigator tool on Lexis Advance ® combines medical and legal research content with a user’s case facts, so that attorneys can quickly assess the value of a case, understand the medical issues and standard of care, identify potential expert witnesses and access relevant medical and legal content – all in one place.

“The nature of medical malpractice litigation requires attorneys to carefully comb through volumes of complex legal and medical research, as well as outside data sources to formulate and develop their case strategies,” said Aileen Stirling, Vice President, Federal & State Litigation Portfolio at LexisNexis. “This can be arduous and time consuming. MedMal Navigator is designed to save attorneys time, money and resources by simplifying this process through a single online dashboard that uses interactive Q&A technology. It puts all of the relevant data right at the attorney’s fingertips.”

The MedMal Navigator dashboard fills a critical gap for medical malpractice attorneys by addressing and relieving many of the pain points they commonly face, including:

  • Accessing Medical Research and Understanding the Medical Issues - MedMal Navigator gives medical malpractice attorneys access to premier medical information, as used by doctors and hospitals, including the expansive collection of health information from Elsevier ®, the world's leading provider of science and health information. It also enables them to search thousands of medical definitions, guides, journals, abstracts and medical images through one single source, enabling them to understand the medicine and quickly determine if and where a deviation in the standard of care may have occurred.
  • Comparing Similar Verdicts & Settlements and Finding the Right Expert - MedMal Navigator allows attorneys to compare verdicts and settlements from prior similar cases to efficiently assess the merits of a case, as well as find and research experts’ profiles by disease, condition and jurisdiction. This ensures that attorneys are armed with the critical insight they need to determine the best course of action for their case and formulate appropriate case strategies.

“For the first time, I can access medical research materials in one place, even those hard-to-find materials,” said Darren W. Dummit, Associate and Manager of the Employment Law Division at Dummit, Buchholz & Trapp. “I can also quickly compare similar verdicts and settlements and spot any issues or deviations from the standard of care, allowing me to determine in 20 minutes versus 20 days if a case is worth taking on. This tool is a powerful, one-stop solution for malpractice attorneys.”

Stock quotes in this article: ENL, RUK 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,262.56 +89.32 0.55%
S&P 500 1,842.98 +12.37 0.68%
NASDAQ 4,034.1610 +11.4670 0.29%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs